Boston Scientific
902 hedge funds and large institutions have $57.1B invested in Boston Scientific in 2022 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 358 increasing their positions, 290 reducing their positions, and 85 closing their positions.
56% more funds holding in top 10
Funds holding in top 10: 9 → 14 (+5)
23% more repeat investments, than reductions
Existing positions increased: 358 | Existing positions reduced: 290
13% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 85
1% more funds holding
Funds holding: 889 → 902 (+13)
0.32% less ownership
Funds ownership: 90.6% → 90.28% (-0.32%)
4% less capital inflows, than outflows
Capital inflows: $3.16B | Capital outflows: $3.28B
14% less call options, than puts
Call options by funds: $312M | Put options by funds: $361M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$296M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$278M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$233M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$138M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$93.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$628M |
| 2 |
Newport Trust Company
Washington,
District of Columbia
|
-$330M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$268M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$265M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$251M |
BSX Hedge Fund Activity: Q1 2022 in Review
902 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2022, worth a combined $57.1B — up 4% from $54.9B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new BSX positions and 85 closed out — a net gain of 11 holders — while 358 added to existing stakes and 290 trimmed.
The largest buyer was DZ Bank, adding an estimated $296M. The largest seller was Janus Henderson Group, cutting an estimated $628M.
- 902 institutional investors held Boston Scientific (BSX) as of Q1 2022, up from 889 in Q4 2021.
- Funds reported $57.1B of Boston Scientific stock for Q1 2022, up 4% quarter-over-quarter.
- 96 funds opened new Boston Scientific positions in Q1 2022 and 85 closed out, a net change of +11 holders.
- The largest Boston Scientific buyer in Q1 2022 was DZ Bank, an estimated $296M added.
- The largest Boston Scientific seller in Q1 2022 was Janus Henderson Group, an estimated $628M sold.
Based on aggregated 13F filings for Q1 2022.